CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enumeral Biomedical Holdings, Inc. (OTCQB:ENUM) (“Enumeral” or the “Company”), a biotechnology company focused on discovering and developing novel antibody immunotherapies that help the immune system fight cancer and other diseases, today announced that Arthur H. Tinkelenberg, Ph.D., Enumeral’s President and Chief Executive Officer, will present a corporate overview at Biotech Showcase 2016 on Wednesday, January 13, 2016 at 9:30 a.m. Pacific Time at the Parc 55 Hotel in San Francisco, CA.
